We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+12.4%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$237M
AUM Growth
+$61.7M
Cap. Flow
+$42.4M
Cap. Flow %
17.92%
Top 10 Hldgs %
29.74%
Holding
101
New
35
Increased
9
Reduced
16
Closed
26

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$7.31M
2
BRKR icon
Bruker
BRKR
+$5.5M
3
LIVN icon
LivaNova
LIVN
+$4.1M
4
SPNC
Spectranetics Corp
SPNC
+$3.7M
5
COO icon
Cooper Companies
COO
+$3.58M

Top Sells

Rank Stock Value
1
SYK icon
Stryker
SYK
+$5.02M
2
BHC icon
Bausch Health
BHC
+$4.13M
3
CYBX
CYBERONICS INC
CYBX
+$3.65M
4
ABT icon
Abbott
ABT
+$3.22M
5
VAR
Varian Medical Systems, Inc.
VAR
+$2.95M

Sector Composition

Rank Sector Weight
1 Healthcare 56.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
76
Abbott
ABT
$190B
– –
-80,000
Closed -$3.22M
BHC icon
77
Bausch Health
BHC
$2.33B
– –
-23,125
Closed -$4.13M
CPRX
78
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-100,129
Closed -$300K
EW icon
79
Edwards Lifesciences
EW
$54B
– –
-105,000
Closed -$2.73M
EWA icon
80
PUT
iShares MSCI Australia ETF
EWA
$1.46B
– –
-100,000
Closed -$1.79M
HOLX
81
CALL
DELISTED
Hologic
HOLX
– –
-100,000
Closed -$3.91M
JAZZ icon
82
Jazz Pharmaceuticals
JAZZ
$16.1B
– –
-18,000
Closed -$2.39M
JNJ icon
83
PUT
Johnson & Johnson
JNJ
$626B
– –
-50,000
Closed -$4.67M
PEN icon
84
Penumbra
PEN
$12.9B
– –
-25,800
Closed -$1.03M
PRGO icon
85
Perrigo
PRGO
$1.78B
– –
-17,500
Closed -$2.75M
PTCT icon
86
CALL
PTC Therapeutics
PTCT
$6.15B
– –
-15,000
Closed -$401K
SAGE
87
DELISTED
Sage Therapeutics
SAGE
– –
-28,000
Closed -$1.19M
SNN icon
88
CALL
Smith & Nephew
SNN
$12.6B
– –
-150,000
Closed -$5.25M
SNN icon
89
Smith & Nephew
SNN
$12.6B
– –
-55,000
Closed -$1.93M
VNDA icon
90
Vanda Pharmaceuticals
VNDA
$298M
– –
-247,500
Closed -$2.79M
ALIM
91
CALL
DELISTED
Alimera Sciences
ALIM
– –
-83,333
Closed -$2.76M
VAR
92
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-45,615
Closed -$2.95M
EVAR
93
DELISTED
Lombard Medical, Inc.
EVAR
– –
-52,875
Closed -$189K
ZLTQ
94
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
– –
-50,000
Closed -$1.6M
FEIC
95
DELISTED
FEI COMPANY
FEIC
– –
-10,000
Closed -$730K
BXLT
96
DELISTED
BAXALTA INC COM STK (DE)
BXLT
– –
-80,000
Closed -$2.52M
DYAX
97
DELISTED
DYAX CORPORATION
DYAX
– –
-23,500
Closed -$449K
CYBX
98
DELISTED
CYBERONICS INC
CYBX
– –
-60,000
Closed -$3.65M
BDSI
99
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-135,000
Closed -$751K
BCR
100
DELISTED
CR Bard Inc.
BCR
– –
-10,000
Closed -$1.86M
1 2 3
4

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2015 Portfolio in Review

As of Q4 2015, Pura Vida Investments held 101 positions worth $237M, up 35% from $175M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Pura Vida Investments deployed $42.4M of net new capital in Q4 2015, opening 35 new positions and adding to 9 existing holdings. Its largest new stake was Baxter International: 200,000 shares worth $7.63M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 66% a quarter earlier.

On the sell side, the largest reduction was Stryker, an estimated $5.02M trimmed.

  • Pura Vida Investments's largest Q4 2015 buy was Baxter International: 200,000 shares worth $7.63M.
  • Pura Vida Investments added most to Accendra Health in Q4 2015, an estimated $2.75M increase.
  • Pura Vida Investments's biggest Q4 2015 reduction was Stryker, cutting an estimated $5.02M.
  • Pura Vida Investments fully exited Bausch Health in Q4 2015, selling an estimated $4.13M.
  • Pura Vida Investments's ten largest holdings make up 30% of its $237M portfolio in Q4 2015.
  • Pura Vida Investments opened 35 new positions and closed 26 in Q4 2015.
  • Pura Vida Investments's portfolio value rose 35% quarter-over-quarter to $237M.

Based on Pura Vida Investments's 13F filing for Q4 2015, filed 16 Feb 2016.